Tami, Joseph A
Ionis Pharmaceuticals (United States)
2 papers on CoChat
Most cited papers
- Verified
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Viney, N. J., van Capelleveen, J. C., Geary, R. S., Xia, S., Tami, J. A., Yu, R. Z., Marcovina, S. M., Hughes, S. G., Graham, M. J., Crooke, R. M., et al. (2016) · The Lancet
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 754
- Verified
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
Tardif, J.-C., Karwatowska-Prokopczuk, E., Amour, E. S., Ballantyne, C. M., Shapiro, M. D., Moriarty, P. M., Baum, S. J., Hurh, E., Bartlett, V. J., Kingsbury, J., et al. (2022) · European Heart Journal
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 210
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free